Improvements in Neurocognitive Function and Mood Following Adjunctive Treatment with Mifepristone (RU-486) in Bipolar Disorder
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
High cortisol levels are found in severe mood disorders, particularly bipolar disorder. Hypercortisolaemia may cause or exacerbate both neurocognitive impairment and depressive symptoms. We hypothesized that antiglucocorticoid treatments, particularly corticosteroid receptor antagonists, would improve neurocognitive functioning and attenuate depressive symptoms in this disorder. To test this hypothesis, 20 bipolar patients were treated with 600 mg/day of the corticosteroid receptor antagonist mifepristone (RU-486) or placebo for 1 week in a double-blind crossover design. Over the total 6 weeks of the study, neurocognitive and neuroendocrine function were evaluated at baseline, days 21 and 42. Mood symptoms were evaluated weekly. Nineteen subjects completed the protocol; there were no drop-outs due to adverse events. Following treatment with mifepristone, selective improvement in neurocognitive functioning was observed. Spatial working memory performance was significantly improved compared to placebo (19.8% improvement over placebo). Measures of verbal fluency and spatial recognition memory were also improved after mifepristone. Beneficial effects on mood were found; Hamilton Depression Rating Scale scores were significantly reduced compared to baseline (mean reduction of 5.1 points) as were Montgomery-Asberg Depression Rating Scale scores (mean reduction of 6.05 points). No significant change occurred after placebo. These data require replication but provide preliminary evidence that glucocorticoid receptor antagonists may have useful cognitive-enhancing and possibly antidepressant properties in bipolar disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“drugs targeting the HPA axis can improve BD symptoms (Young et al. 2004;Young ,2014;Juruena et al. 2009).”
From The HPA axis in bipolar disorder: Systematic review and meta-analysis (2016) · cites this paper as Young et al. 2004
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 3×
“…symptomatic improvement, the antidepressant effect of mifepristone was the principal focus, therefore the outcome measures of interest were the 17-item Hamilton Depression Rating Scale (HDRS17; Hamilton, 1960) and the Montgomery–Asberg Depression Rating Scale (MADRS; Montgomery and Asberg, 1979).”
MethodInfluentialA new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · cited 3×
“…symptomatic improvement, the antidepressant effect of mifepristone was the principal focus, therefore the outcome measures of interest were the 17-item Hamilton Depression Rating Scale (HDRS17; Hamilton, 1960) and the Montgomery–Asberg Depression Rating Scale (MADRS; Montgomery and Asberg, 1979).”
MethodInfluentialKessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370 · cited 1×
“Bipolar disorder is a chronic and recurrent illness, with a lifetime incidence of at least 1% (Kessler et al, 1994).”
BackgroundThe Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090 · cited 1×
“Other secondary scales consisted of the Brief Psychiatric Rating Scale (BPRS; Overall and Gorham, 1962) and the Young Mania Rating Scale (YMRS; Young et al, 1978).”
MethodA Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744 · cited 1×
“Other secondary scales consisted of the Brief Psychiatric Rating Scale (BPRS; Overall and Gorham, 1962) and the Young Mania Rating Scale (YMRS; Young et al, 1978).”
MethodNeuropsychological assessment.
Cipolotti, L., & Warrington, E. K. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.6.655 · Cited by 3,234
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106 · cited 1×
“Although the illness is defined by the occurrence of mania, the depressed phase predominates (Judd et al, 2002, 2003) and represents the greatest therapeutic challenge.”
BackgroundGlucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016 · cited 2×
“It has been suggested that abnormalities in hypothalamic–pituitary– adrenal (HPA) axis function may cause or exacerbate both neurocognitive impairment and depressive symptoms (McQuade and Young, 2000; Sapolsky, 2000).”
BackgroundSmithson, M. (2000) · SAGE Publications Ltd eBooks · doi:10.4135/9781446218525 · Cited by 1,871
Judd, L. L., Akiskal, H. S., Schettler, P. J., Coryell, W., Endicott, J., Maser, J. D., Solomon, D. A., Leon, A. C., & Keller, M. B. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.3.261 · Cited by 1,243 · cited 1×
“Although the illness is defined by the occurrence of mania, the depressed phase predominates (Judd et al, 2002, 2003) and represents the greatest therapeutic challenge.”
BackgroundThe acute effects of corticosteroids on cognition: integration of animal and human model studies
LUPIEN, S., & MCEWEN, B. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00004-0 · Cited by 1,024 · cited 1×
“In healthy volunteers, both acute (Lupien and McEwen, 1997) and subchronic (Young et al, 1999) administration of the synthetic steroid, hydrocortisone, causes reversible impairments in neurocognitive function.”
BackgroundAcute cortisone administration impairs retrieval of long-term declarative memory in humans
de Quervain, D. J.-F., Roozendaal, B., Nitsch, R. M., McGaugh, J. L., & Hock, C. (2000) · Nature Neuroscience · doi:10.1038/73873 · Cited by 745 · cited 2×
“This may be the result of a specific deficit in memory retrieval (de Quervain et al, 2000, 2003), although there is evidence to suggest that working memory function may be more sensitive than declarative memory to the effects of elevated corticosteroid levels (Lupien et al, 1999; Young et al, 1999).”
BackgroundMethodLupien, S. J., Gillin, C. J., & Hauger, R. L. (1999) · Behavioral Neuroscience · doi:10.1037/0735-7044.113.3.420 · Cited by 561 · cited 2×
“This may be the result of a specific deficit in memory retrieval (de Quervain et al, 2000, 2003), although there is evidence to suggest that working memory function may be more sensitive than declarative memory to the effects of elevated corticosteroid levels (Lupien et al, 1999; Young et al, 1999).”
BackgroundMethodDecreased memory performance in healthy humans induced by stress-level cortisol treatment
Newcomer, J. W. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.6.527 · Cited by 546 · cited 2×
“Several studies have reported reduced verbal declarative memory function (Newcomer et al, 1999).”
BackgroundMethodOwen, A. M., Sahakian, B. J., Semple, J., Polkey, C. E., & Robbins, T. W. (1995) · Neuropsychologia · doi:10.1016/0028-3932(94)00098-a · Cited by 525 · cited 1×
“This may underpin the selective pattern of improvement in neurocognitive function seen in the present study, which was restricted to tests which have been shown to be sensitive to frontal lobe dysfunction (Owen et al, 1995).”
Neuropsychological function in euthymic patients with bipolar disorder
Ferrier, I. N., Stanton, B. R., Kelly, T. P., & Scott, J. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.3.246 · Cited by 426 · cited 1×
“…dysfunction is also frequently described in symptomatic bipolar patients and there is increasing evidence of specific impairments which may persist in euthymia and therefore represent a relatively enduring abnormality (Ferrier et al, 1999; Ferrier and Thompson, 2002; Thompson et al, 2000).”
BackgroundWebster, M. J., Knable, M. B., O'Grady, J., Orthmann, J., & Weickert, C. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001139 · Cited by 420 · cited 1×
“It is also supported by post-mortem studies which show evidence of reduced GR mRNA expression in post-mortem brain tissue samples from patients with bipolar disorder (Knable et al, 2001; Lopez et al, 2003; Webster et al, 2002).”
ResultHypothalamic-pituitary-adrenal axis function in patients with bipolar disorder
Watson, S., Gallagher, P., Ritchie, J. C., Ferrier, I. N., & Young, A. H. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.496 · Cited by 343 · cited 1×
“It is also supported by post-mortem studies which show evidence of reduced GR mRNA expression in post-mortem brain tissue samples from patients with bipolar disorder (Knable et al, 2001; Lopez et al, 2003; Webster et al, 2002).”
ResultSelf-citationDe Quervain, D. J. ‐., Henke, K., Aerni, A., Treyer, V., McGaugh, J. L., Berthold, T., Nitsch, R. M., Buck, A., Roozendaal, B., & Hock, C. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02542.x · Cited by 342 · cited 2×
“This may be the result of a specific deficit in memory retrieval (de Quervain et al, 2000, 2003), although there is evidence to suggest that working memory function may be more sensitive than declarative memory to the effects of elevated corticosteroid levels (Lupien et al, 1999; Young et al, 1999).”
BackgroundMethodAn open label trial of C-1073 (mifepristone) for psychotic major depression*
Belanoff, J. K., Rothschild, A. J., Cassidy, F., DeBattista, C., Baulieu, E.-E., Schold, C., & Schatzberg, A. F. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01432-4 · Cited by 320
Dorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3834 · Cited by 260 · cited 1×
“…and have consistently been shown to be associated with significant neurocognitive impairment (Forget et al, 2000; Mauri et al, 1993; Starkman et al, 2001; Whelan et al, 1980) and a high incidence of depression, which notably resolves with correction of the hypercortisolaemia (Dorn et al, 1997).”
BackgroundHART, A. R. (2001) · Postgraduate Medical Journal · doi:10.1136/pmj.77.908.423d · Cited by 246
Young, A. H., Sahakian, B. J., Robbins, T. W., & Cowen, P. J. (1999) · Psychopharmacology · doi:10.1007/s002130051057 · Cited by 244 · cited 3×
“This may be the result of a specific deficit in memory retrieval (de Quervain et al, 2000, 2003), although there is evidence to suggest that working memory function may be more sensitive than declarative memory to the effects of elevated corticosteroid levels (Lupien et al, 1999; Young et al, 1999).”
BackgroundSelf-citationRybakowski, J. K., & Twardowska, K. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00014-x · Cited by 213 · cited 1×
“…nonsuppressors (Rush et al, 1996) and that the dexamethasone/corticotropin releasing hormone (dex/CRH) test is abnormal during relapse, recovery (Rybakowski and Twardowska, 1999; Schmider et al, 1995; Watson et al, in press) and in apparently healthy subjects with genetic loading for mood…”
BackgroundElevated Cortisol Levels in Cushing’s Disease Are Associated With Cognitive Decrements
Starkman, M. N., Giordani, B., Berent, S., Schork, M. A., & Schteingart, D. E. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200111000-00018 · Cited by 206 · cited 1×
“…cortisol levels and have consistently been shown to be associated with significant neurocognitive impairment (Forget et al, 2000; Mauri et al, 1993; Starkman et al, 2001; Whelan et al, 1980) and a high incidence of depression, which notably resolves with correction of the hypercortisolaemia (Dorn…”
BackgroundSchmider, J., Lammers, C.-H., Gotthardt, U., Dettling, M., Holsboer, F., & Heuser, I. J. E. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00064-x · Cited by 179 · cited 1×
“…et al, 1996) and that the dexamethasone/corticotropin releasing hormone (dex/CRH) test is abnormal during relapse, recovery (Rybakowski and Twardowska, 1999; Schmider et al, 1995; Watson et al, in press) and in apparently healthy subjects with genetic loading for mood disorders (Lauer et al, 1998).”
BackgroundThe Dexamethasone Suppression Test in Patients With Mood Disorders
Rush, A. J., Giles, D. E., Schlesser, M. A., Orsulak, P. J., Parker, C. R., Weissenburger, J. E., Crowley, G. T., Khatami, M., & Vasavada, N. (1996) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v57n1006 · Cited by 174 · cited 2×
“…mood disorders, the greatest incidence of HPA axis abnormalities are found in bipolar and psychotic unipolar disorder (Rush et al, 1996) and reduction of cortisol levels in these conditions may therefore ameliorate depression and improve neurocognitive functioning…”
BackgroundResultCognitive decline in patients with Cushing's syndrome
FORGET, H., LACROIX, A., SOMMA, M., & COHEN, H. (2000) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700611037 · Cited by 161
Future therapeutic targets in mood disorders: the glucocorticoid receptor
McQuade, R., & Young, A. H. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.5.390 · Cited by 156 · cited 4×
“It has been suggested that abnormalities in hypothalamic–pituitary– adrenal (HPA) axis function may cause or exacerbate both neurocognitive impairment and depressive symptoms (McQuade and Young, 2000; Sapolsky, 2000).”
BackgroundInfluentialSelf-citationMemory impairment in Cushing's disease
Mauri, M., Sinforiani, E., Bono, G., Vignati, F., Berselli, M. E., Attanasio, R., & Nappi, G. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04075.x · Cited by 151 · cited 1×
“…of endogenous cortisol levels and have consistently been shown to be associated with significant neurocognitive impairment (Forget et al, 2000; Mauri et al, 1993; Starkman et al, 2001; Whelan et al, 1980) and a high incidence of depression, which notably resolves with correction of the…”
BackgroundKnable, M. B., Torrey, Ε. F., Webster, M. J., & Bartko, J. J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00521-4 · Cited by 135 · cited 1×
“It is also supported by post-mortem studies which show evidence of reduced GR mRNA expression in post-mortem brain tissue samples from patients with bipolar disorder (Knable et al, 2001; Lopez et al, 2003; Webster et al, 2002).”
ResultCognitive impairment in bipolar affective disorder: implications for the bipolar diathesis
Ferrier, I. N., & Thompson, J. M. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.4.293 · Cited by 129 · cited 2×
“Pronounced neurocognitive dysfunction is also frequently described in symptomatic bipolar patients and there is increasing evidence of specific impairments which may persist in euthymia and therefore represent a relatively enduring abnormality (Ferrier et al, 1999; Ferrier and Thompson, 2002; Thompson et al, 2000).”
BackgroundNeuropsychological Deficits in Cushing??s Syndrome
WHELAN, T. B., SCHTEINGART, D. E., STARKMAN, M. N., & SMITH, A. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198012000-00008 · Cited by 128 · cited 1×
“…and have consistently been shown to be associated with significant neurocognitive impairment (Forget et al, 2000; Mauri et al, 1993; Starkman et al, 2001; Whelan et al, 1980) and a high incidence of depression, which notably resolves with correction of the hypercortisolaemia (Dorn et al, 1997).”
BackgroundAntiglucocorticoid drugs in the treatment of depression
Reus, V. I., & Wolkowitz, O. M. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.10.1789 · Cited by 82 · cited 2×
“In mood disorders, the greatest incidence of HPA axis abnormalities are found in bipolar and psychotic unipolar disorder (Rush et al, 1996) and reduction of cortisol levels in these conditions may therefore ameliorate depression and improve neurocognitive functioning (Reus and Wolkowitz, 2001).”
BackgroundBachmann, C. G., Linthorst, A. C. E., Holsboer, F., & Reul, J. M. H. M. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300158 · Cited by 79 · cited 1×
“Interestingly, RU-486 was the only GR antagonist examined in a recent study to increase both mineralocorticoid receptor (MR) and GR binding in the frontal cortex (Bachmann et al, 2003).”
BackgroundLauer, C. J., Schreiber, W., Modell, S., Holsboer, F., & Krieg, J. C. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00026-0 · Cited by 47 · cited 1×
“…et al, 1996) and that the dexamethasone/corticotropin releasing hormone (dex/CRH) test is abnormal during relapse, recovery (Rybakowski and Twardowska, 1999; Schmider et al, 1995; Watson et al, in press) and in apparently healthy subjects with genetic loading for mood disorders (Lauer et al, 1998).”
BackgroundKetoconazole in bipolar patients with depressive symptoms: a case series and literature review
Brown, E. S., Bobadilla, L., & Rush, A. J. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.030103.x · Cited by 45 · cited 1×
“In keeping with this view, preliminary data suggests that cortisol synthesis inhibitors may be antidepressant (Brown et al, 2001).”
BackgroundHeikinheimo, O., Raivio, T., Honkanen, H., Ranta, S., & Jänne, O. (2003) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2002-020799 · Cited by 18 · cited 2×
“A recent study has reported a persistent reduction in glucocorticoid bioactivity after a single dose of mifepristone (200 mg) which normalized 2 weeks after the treatment (Heikinheimo et al, 2003).”
Background
Research works printed but not linked: 5
- Cegalis J, Bowlin J (1991). Vigil: Software for the Assessment of Attention. Forthought: Nashua, NH.
- First MB, Spitzer RL, Williams JBW, Gibbon M (1995). Structured Clinical Interview for DSM-IV (SCID-I), Research Version. Biometrics Research Department, New York State Psychiatric Institute: New York.
- Høyberg ØJ, Wik G, Mehtonen OP, Peeters BWMM, Sennef C (2002). ORG 34517, a selective glucocorticoid receptor antagonist with potent antidepressant activity: first clinical results. Int J Neuropsychopharmacol 5: S148.
- Lopez JF, Little KY, Lopez-Figueroa AL, Lopez-Figueroa MO, Watson SJ (2003). Glucocorticoid and mineralocorticoid receptor mRNA levels in the hippocampus and prefrontal cortex of subjects with mood disorders and schizophrenia. Biol Psychiatry 53: 489.
- Thompson JM, Gray JM, Hughes J, Watson S, Ferrier I, Young AH (2000). A component process analysis of working memory dysfunction in bipolar affective disorder. J Psychopharmacol (Oxf) 14: A24.
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
The HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009
Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., Murphy, G. M., & Schatzberg, A. F. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.120 · Cited by 922
“In addition, Young's group reported that the GR antagonist mifepristone significantly improves visual memory in bipolar depression (31).”
BackgroundThe glucocorticoid receptor: Pivot of depression and of antidepressant treatment?
Anacker, C., Zunszain, P. A., Carvalho, L. A., & Pariante, C. M. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.007 · Cited by 592
Metadata
- Authors
- Young, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Young, Allan H
- Venue
- Neuropsychopharmacology
- Published
- 2004-05-05
- Volume
- 29
- Issue
- 8
- Pages
- 1538-1545
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2041573038
- Cited by
- 318
- References
- 38
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 13 · 2023: 6 · 2022: 2 · 2021: 11 · 2020: 9 · 2019: 5 · 2018: 14 · 2017: 8 · 2016: 16 · 2015: 13 · 2014: 18 · 2013: 12 · 2012: 14
- FWCI
- 15.34
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Stanley Medical Research Institute
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- mifepristone, RU486, bipolar disorder, glucocorticoid receptor antagonist, hypercortisolism, neurocognitive function, spatial working memory, verbal fluency, spatial recognition memory, depressive symptoms, antidepressant effects, cognitive enhancement
- MeSH terms
- Adult, Affect, Attention, Bipolar Disorder, Cognition, Double-Blind Method, Female, Hormone Antagonists, Humans, Hydrocortisone, Learning, Male, Memory, Short-Term, Middle Aged, Psychiatric Status Rating Scales, Psychomotor Performance, Receptors, Glucocorticoid, Space Perception, Verbal Learning, Mifepristone, Treatment Outcome, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.